Device beats drugs for atrial fib

A Johnson & Johnson unit released study data yesterday showing that its catheter-based system might be more effective than drugs are at resolving heart arrhythmias. The company's Biosense Webster unit is hoping to gain FDA approval to market the device for the treatment of atrial fibrillation, making it the first approved device to treat the condition. AtriCure , Boston Scientific, Medtronic and St. Jude Medical all have competing devices, but none have received FDA approval for the condition to date. Report


Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.